Literature DB >> 30963277

CT diagnostic reference levels: are they appropriately computed?

Thibault Vanaudenhove1, Alain Van Muylem2, Nigel Howarth3, Pierre Alain Gevenois4, Denis Tack5.   

Abstract

OBJECTIVES: To estimate the variability of CT diagnostic reference levels (DRLs) according to the methods used for computing collected data.
METHODS: Dose-length products (DLP) were collected by our national nuclear control agency from the 250 devices installed in 140 medical centers in the country. In 2015, the number of head, thorax, abdomen, and lumbar spine examinations collected in these centers ranged from approximately 20,000 to 42,000. The impact on DRLs of the number of devices considered, as well as the differences in descriptive statistics (mean vs. median DLP) or methods of pooling DLP data (all devices vs. all patients), was investigated. Variability in DRLs was investigated using a bootstrapping method as a function of the numbers of devices and examinations per device.
RESULTS: As expected, DRLs derived from means were higher than those from medians, with substantial differences between device- and patient-related DRLs. Depending on the numbers of devices and DLP data per device, the variability ranged from 10 to 40% but was stabilized at a level of 10-20% if the number of devices was higher than 50 to 60, regardless of the number of DLP data per device.
CONCLUSION: Number of devices and of DLP data per device, descriptive statistics, and pooling data influence DRLs. As differences in methods of computing survey data can artificially influence DRLs, harmonization among national authorities should be recommended. KEY POINTS: • Due to CT dose variability, that of DRLs is at least of 10%. • DRLs derived from medians are lower than from means and differ from those obtained by pooling all patient data. • Fifty to 60 devices should be sufficient for estimating national DRLs, regardless of the number of data collected per device.

Entities:  

Keywords:  Radiation protection; Surveys and questionnaires; Tomography

Mesh:

Year:  2019        PMID: 30963277     DOI: 10.1007/s00330-019-06141-8

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  6 in total

Review 1.  Dosimetry for optimisation of patient protection in computed tomography.

Authors:  K A Jessen; P C Shrimpton; J Geleijns; W Panzer; G Tosi
Journal:  Appl Radiat Isot       Date:  1999-01       Impact factor: 1.513

2.  Predictors of CT Radiation Dose and Their Effect on Patient Care: A Comprehensive Analysis Using Automated Data.

Authors:  Rebecca Smith-Bindman; Yifei Wang; Thomas R Yellen-Nelson; Michelle Moghadassi; Nicole Wilson; Robert Gould; Anthony Seibert; John M Boone; Mayil Krishnam; Ramit Lamba; David J Hall; Diana L Miglioretti
Journal:  Radiology       Date:  2016-07-20       Impact factor: 11.105

3.  Multidetector CT radiation dose optimisation in adults: short- and long-term effects of a clinical audit.

Authors:  Denis Tack; Andreas Jahnen; Sarah Kohler; Nico Harpes; Viviane De Maertelaer; Carlo Back; Pierre Alain Gevenois
Journal:  Eur Radiol       Date:  2013-08-29       Impact factor: 5.315

4.  National survey of doses from CT in the UK: 2003.

Authors:  P C Shrimpton; M C Hillier; M A Lewis; M Dunn
Journal:  Br J Radiol       Date:  2006-12       Impact factor: 3.039

5.  ICRP Publication 135: Diagnostic Reference Levels in Medical Imaging.

Authors:  E Vañó; D L Miller; C J Martin; M M Rehani; K Kang; M Rosenstein; P Ortiz-López; S Mattsson; R Padovani; A Rogers
Journal:  Ann ICRP       Date:  2017-10

6.  CT dose survey in adults: what sample size for what precision?

Authors:  Stephen Taylor; Alain Van Muylem; Nigel Howarth; Pierre Alain Gevenois; Denis Tack
Journal:  Eur Radiol       Date:  2016-04-05       Impact factor: 5.315

  6 in total
  1 in total

1.  Update of national diagnostic reference levels for adult CT in Switzerland and assessment of radiation dose reduction since 2010.

Authors:  Christoph Aberle; Nick Ryckx; Reto Treier; Sebastian Schindera
Journal:  Eur Radiol       Date:  2019-11-20       Impact factor: 5.315

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.